Circadian Stage-Dependent Inhibition of Human Breast Cancer Metabolism and Growth by the Nocturnal Melatonin Signal: Consequences of Its Disruption by Light at Night in Rats and Women

The circadian production of melatonin by the pineal gland during the night provides an inhibitory signal to tissue-isolated steroid receptor SR+ and — MCF-7 human breast cancer xenografts in female nude rats. A pivotal mechanism for melatonin’s anticancer effects in vivo involves a melatonin receptor-mediated inhibition of linoleic acid (LA) uptake and its metabolism to mitogenically active 13-hydroxyoctadecadienoic acid (13-HODE). Exposure of (SR-) xenograft-bearing rats to increasing intensities of polychromatic white light at night suppresses melatonin while increasing tumor growth rates, DNA content, [3H]thymidine incorporation into DNA, LA uptake, 13-HODE formation, cAMP levels and ERK1/2 activation a dose-dependent manner. Similar effects occur in SR- human breast cancer …

Related posts:

1. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
2. Molecular Mechanisms of Melatonin Anticancer Effects
3. Dissociation of circadian and light inhibition of melatonin release through forced desynchronization in the rat [Neuroscience]
4. Pre- and post-treatment of streptozocin administered rats with melatonin: effects on some hepatic enzymes of carbohydrate metabolism.
5. Controlled Patterns of Daytime Light Exposure Improve Circadian Adjustment in Simulated Night Work